Nu-Med Plus, Inc. (NUMD)

Market Cap	793.71K -82.7%
Revenue (ttm)	n/a
Net Income	-52.13K
EPS	-0.00
Shares Out	83.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	190
Open	0.0095
Previous Close	0.0095
Day's Range	0.0095 - 0.0095
52-Week Range	0.0095 - 0.0500
Beta	-2.39
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Nu-Med Plus

Nu-Med Plus, Inc., a medical device company, engages in the design, innovation, development, enhancement, and commercialization of medical devices worldwide. The company develops a nitric oxide generating formulation; a hospital bedside nitric oxide delivery system; a clinical unit for use in medical clinics and rehabilitation centers. It is also involved in the development of a mobile rechargeable device to deliver nitric oxide gas; and a nitric oxide system that can be used for research applications, as well as a mobile/portable rechargeable ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: NUMD

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error